Comparing effect of intravenous parecoxib for acute pain management before and after incision in total abdominal hysterectomy
Phase 4
Recruiting
- Conditions
- post operative acute pain managementacute pain management in total abdominal hysterectomy
- Registration Number
- TCTR20230524003
- Lead Sponsor
- Makarak Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
1. 18-65 years old
2. total abdominal hysterectomy operation, midline incision
3. no underlyling disease eg. myocardial infarction, congestive heart failure, GI bleeding, stroke
4. no drug allergy to parecoxib, NSAIDs, sulfonamides, aspirin and bupivacaine
5. serum creatinine < 1.5 mg/dL
6. no hepatic failure(Child-Pugh Class C)
Exclusion Criteria
1. withdrawal from this study
2. operation under general anesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain score 6, 12, 18, 24 hours after surgery visual analogue scale
- Secondary Outcome Measures
Name Time Method tramadol consumption first 24 hours after surgery mg